Anifrolumab FDA approval to treat systemic lupus [Saphnelo]

posted in All on August 2, 2021 by

Donald Thomas

Leave a comment

Anifrolumab FDA Approval to Treat Systemic Lupus Erythematosus (SLE)

AstraZeneca announced its anifrolumab FDA approval on 8/2/2021. In this blog, learn how anifrolumab works, how it is given, and its potential side effects. If you are a patient with lupus …